DNAVSEDD• 28 Days (Normalized)
DNA vs EDD (Ginkgo Bioworks Holdings Inc. vs Morgan Stanley Emerging Markets Domestic Debt Fund Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $13
+92.59%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
EDD Performance $5.34
-9.64%
Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+102.23 pts
DNA outperforming by 102.23 percentage points
DNAEDD
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA EDD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | DNA Price | DNA Gain (%) | EDD Price | EDD Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $13.00 | +92.59% | $5.34 | -9.64% | +102.23% |
| Oct 08, 2026 | $11.34 | +68.00% | $5.28 | -10.66% | +78.66% |
| Oct 07, 2026 | $11.47 | +69.93% | $5.21 | -11.84% | +81.77% |
| Oct 06, 2026 | $12.41 | +83.85% | $5.33 | -9.81% | +93.66% |
| Oct 05, 2026 | $14.98 | +121.93% | $5.24 | -11.34% | +133.27% |
| Oct 02, 2026 | $12.35 | +82.96% | $5.34 | -9.64% | +92.60% |
| Oct 01, 2026 | $12.50 | +85.19% | $- | - | |
| Sep 30, 2026 | $12.83 | +90.07% | $- | - | |
| Sep 29, 2026 | $11.96 | +77.19% | $5.51 | -6.77% | +83.96% |
| Sep 28, 2026 | $10.46 | +54.96% | $5.58 | -5.58% | +60.54% |
| Sep 25, 2026 | $10.66 | +57.93% | $5.60 | -5.25% | +63.18% |
| Sep 24, 2026 | $10.25 | +51.85% | $5.53 | -6.43% | +58.28% |
| Sep 23, 2026 | $8.58 | +27.11% | $5.65 | -4.40% | +31.51% |
| Sep 22, 2026 | $9.37 | +38.81% | $5.79 | -2.03% | +40.84% |
| Sep 21, 2026 | $7.98 | +18.22% | $5.79 | -2.03% | +20.25% |
Page 1 of 2